Kotak Sec estimates Paxlovid’s contribution to be US$70mn this quarter (75% of CDMO & 35% of consol sales) & US$50mn in Q1.
Subscribe To Our Free Newsletter |
Kotak Sec estimates Paxlovid’s contribution to be US$70mn this quarter (75% of CDMO & 35% of consol sales) & US$50mn in Q1.
Subscribe To Our Free Newsletter |
EvoLve theme by Theme4Press • Powered by WordPress & Rakesh Jhunjhunwala Latest Stock Market News
The Most Valuable Commodity Is Information!